Search Results - "Sargin, Deniz"
-
1
INFECTION RATES ACROSS THE AUTOLOGOUS STEM CELL TRANSPLANTATION WITH REFLECTION OF MULTIPLE MYELOMA INDUCTION STORY IN TURKEY
Published in Hematology, Transfusion and Cell Therapy (01-10-2023)“…Objective: This study aimed to investigate the frequency of infections after autologous hematopoietic stem cell transplantation (HSCT) in patients who were…”
Get full text
Journal Article -
2
Bortezomib retreatment for relapsed and refractory multiple myeloma in real‐world clinical practice
Published in Health science reports (01-01-2019)“…Aims Studies have shown that bortezomib retreatment is effective in relapsed/refractory multiple myeloma (MM). The observational, prospective electronic…”
Get full text
Journal Article -
3
Effects of Mutational Combinations on Philadelphia-Negative Myeloproliferative Neoplasms
Published in Iranian journal of medical sciences (01-03-2017)Get full text
Journal Article -
4
Plasmacytoma of the Nasolacrimal Duct Simulating Dacryocystitis: An Uncommon Presentation for Extramedullary Relapse of Multiple Myeloma
Published in Case reports in oncology (01-01-2012)“…The most common site for localized forms of plasma cell neoplasms (extramedullary plasmacytoma; EMP) is the upper respiratory tract, including the oropharynx,…”
Get full text
Journal Article -
5
Intracoronary Stem Cell Infusion in Heart Transplant Candidates
Published in The Tohoku Journal of Experimental Medicine (01-10-2007)“…The stem cell transplantation is emerging as a potential therapeutic modality for patients with heart failure. It has been demonstrated that intracoronary stem…”
Get full text
Journal Article -
6
Neoangiogenesis after direct intramyocardial implantation of bone marrow-derived stem cells in a patient with severe coronary artery disease ineligible for percutaneous or surgical revascularization
Published in Central European journal of medicine (01-09-2009)“…Bone marrow-derived stem cells (BMSC) may be an alternative for the treatment of patients with severe coronary artery disease ineligible for either…”
Get full text
Journal Article -
7
Preliminary Report of the Academic CAR-T (ISIKOK-19) Cell Clinical Trial in Turkey: Characterization of Product and Outcomes of Clinical Application
Published in Turkish journal of haematology (25-08-2022)“…ObjectiveChimeric antigen receptor T (CAR-T) cell therapies have already made an impact on the treatment of B-cell malignancies. Although CAR-T cell therapies…”
Get full text
Journal Article -
8
-
9
Clostridium difficile Infection after Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Study
Published in Clinical lymphoma, myeloma and leukemia (01-09-2019)Get full text
Journal Article -
10
P-045: Immunoglobulin V(D) J Recombination, Protein Ubiquitination, Cell Adhesion and Sonic Hedgehog Gene Variants are detected among familial Multiple Myeloma subjects following whole exome sequencing
Published in Clinical lymphoma, myeloma and leukemia (01-10-2021)“…Familial multiple myeloma(MM) cases have been associated with some rare, germline variants, mostly among epigenetic modification genes and needs to be…”
Get full text
Journal Article -
11
Bortezomib‐based therapy for relapsed/refractory multiple myeloma in real‐world medical practice
Published in European journal of haematology (01-10-2018)“…Objective The efficacy and safety of bortezomib‐based therapy for relapsed/refractory multiple myeloma (RRMM) in clinical trials may differ from the oncology…”
Get full text
Journal Article -
12
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
Published in International journal of hematology- oncology and stem cell research (01-01-2017)“…For adult ALL patients, the indications and appropriate timing of allogeneic hematopoietic stem cell transplantation (AHSCT) continue to be debated. The…”
Get full text
Journal Article -
13
Complete Remission of Burkitt Lymphoma After Surgical Excision: A Case Report
Published in Indian journal of hematology & blood transfusion (01-06-2016)“…Burkitt lymphoma (BL) is a highly aggressive B cell non-Hodgkin lymphoma that has a high proliferation rate. The prognosis for BL is generally favorable, with…”
Get full text
Journal Article -
14
Allogeneic Hematopoietic Stem Cell Transplantation for Adult Acute Lymphoblastic Leukemia: Results from a Single Center, 1993-2011
Published in International journal of hematology- oncology and stem cell research (01-12-2016)“…Background: For adult ALL patients, the indications and appropriate timing of allogeneic hematopoietic stem cell transplantation (AHSCT) continue to be…”
Get full text
Journal Article -
15
Allogeneic stem cell transplantation in a blast-phase chronic myeloid leukemia patient with carbapenem-resistant Klebsiella pneumoniae tricuspid valve endocarditis: A case report
Published in Molecular and clinical oncology (01-10-2016)“…In chronic myeloid leukemia (CML), the occurrence of blastic transformation is rare. Treatment outcome is generally poor. Allogeneic stem cell transplantation…”
Get full text
Journal Article -
16
Isolated extramedullary cutaneous relapse despite concomitant severe graft-vs.-host disease and tissue chimerism analysis in a patient with acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: A case report
Published in Molecular and clinical oncology (01-12-2016)“…Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a potentially curative treatment option for patients with acute lymphoblastic leukemia (ALL)…”
Get full text
Journal Article -
17
Thrombotic complications in multiple myeloma: a report of three cases and review of the literature
Published in Journal of thrombosis and thrombolysis (01-02-2012)“…The risk of venous thromboembolism (VTE) increases in the presence of plasma cell dyscrasias. Monoclonal gammopathy of undetermined significance (MGUS) and…”
Get full text
Journal Article -
18
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis
Published in Turkish journal of haematology (05-06-2016)“…The JAK2V617F mutation is present in the majority of patients with essential thrombocythemia (ET) and primary myelofibrosis (PMF). The impact of this mutation…”
Get full text
Journal Article -
19
Impact of HLA-DPB1 Matching in Unrelated Allogeneic Stem Cell Transplantation: Results of Two Centers From Turkey
Published in Uluslararası hematologi-onkoloji dergisi (01-01-2017)Get full text
Journal Article -
20
Prognostic significance of ASXL1, JAK2V617F mutations and JAK2V617F allele burden in Philadelphia-negative myeloproliferative neoplasms
Published in Journal of blood medicine (01-01-2015)“…Despite insights into the genetic basis of Philadelphia-negative myeloproliferative neoplasms (Ph-negative MPNs), a significant proportion of essential…”
Get full text
Journal Article